1. Ascorbic acid recycling by cultured beta cells: effects of increased glucose metabolism. Steffner RJ, Wu L, Powers AC, May JM (2004) Free Radic Biol Med 37(10): 1612-21
    › Primary publication · 15477012 (PubMed)
  2. Engineering physiologically regulated insulin secretion in non-beta cells by expressing glucagon-like peptide 1 receptor. Wu L, Nicholson W, Wu CY, Xu M, McGaha A, Shiota M, Powers AC (2003) Gene Ther 10(19): 1712-20
    › Primary publication · 12923570 (PubMed)
  3. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L (2001) Nat Med 7(9): 1052-6
    › Primary publication · 11533710 (PubMed)
  4. Different functional domains of GLUT2 glucose transporter are required for glucose affinity and substrate specificity. Wu L, Fritz JD, Powers AC (1998) Endocrinology 139(10): 4205-12
    › Primary publication · 9751501 (PubMed)
  5. Gene-based neurotransmitter modulation in cerebellar granule neurons. Fritz JD, Utz AL, Hale NM, Wu L, Powers AC, Verdoorn TA, Robertson D (1997) J Neurochem 68(1): 204-12
    › Primary publication · 8978727 (PubMed)
  6. Two regions of GLUT 2 glucose transporter protein are responsible for its distinctive affinity for glucose. Buchs A, Wu L, Morita H, Whitesell RR, Powers AC (1995) Endocrinology 136(10): 4224-30
    › Primary publication · 7664639 (PubMed)
  7. Coexpression of glucose transporters and glucokinase in Xenopus oocytes indicates that both glucose transport and phosphorylation determine glucose utilization. Morita H, Yano Y, Niswender KD, May JM, Whitesell RR, Wu L, Printz RL, Granner DK, Magnuson MA, Powers AC (1994) J Clin Invest 94(4): 1373-82
    › Primary publication · 7929812 (PubMed) · PMC295259 (PubMed Central)